Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
Status:
Completed
Trial end date:
2019-11-12
Target enrollment:
Participant gender:
Summary
A Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of HNO
Donor in Hospitalized Patients with Heart Failure and Impaired Systolic Function